High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2013-07, Vol.162 (2), p.282-285
Hauptverfasser: Liberante, Fabio G., Pellagatti, Andrea, Boncheva, Viktoriya, Bowen, David T., Mills, Ken I., Boultwood, Jacqueline, Guinn, Barbara‐Ann
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 285
container_issue 2
container_start_page 282
container_title British journal of haematology
container_volume 162
creator Liberante, Fabio G.
Pellagatti, Andrea
Boncheva, Viktoriya
Bowen, David T.
Mills, Ken I.
Boultwood, Jacqueline
Guinn, Barbara‐Ann
description
doi_str_mv 10.1111/bjh.12352
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1381099266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1381099266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</originalsourceid><addsrcrecordid>eNp1kM9u1DAQhy0EokvhwAsgX5BAalo7_xofS9WyoCIQgnM0diati2OnHi8lz9CXxu0ucGIuPsznb2Z-jL2U4lDmOtLXV4eyrJryEVvJqm2KUtbyMVsJIY4LKepujz0juhZCVqKRT9leZlUt2nLF7tb28oqDH7gLtwdcbxL3IXHrE8YJBwsJD_iXryefzjj-miMS2eC5w5_oiENEPocQ-RzDpQ-UrOETxB8YKRv4tKALw0Kzg4cWLX6IYUIOiQ-WECh_z0r0CVLWPmdPRnCEL3bvPvt-fvbtdF1cfH7_4fTkojCVEmWhhDC10sI0Wo0wgNLdCPmerjVSmbbGQepaQNd10A5mGAVg1WqtFHTl2DSy2mdvtt689s0GKfWTJYPOgcewoV5WnRRKlW2b0bdb1MRAFHHs52jziUsvRX-ffZ-z7x-yz-yrnXajc3R_yT9hZ-D1DgAy4MYI3lj6xx03shT1_X5HW-7WOlz-P7F_93G9Hf0bquidZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1381099266</pqid></control><display><type>article</type><title>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><creator>Liberante, Fabio G. ; Pellagatti, Andrea ; Boncheva, Viktoriya ; Bowen, David T. ; Mills, Ken I. ; Boultwood, Jacqueline ; Guinn, Barbara‐Ann</creator><creatorcontrib>Liberante, Fabio G. ; Pellagatti, Andrea ; Boncheva, Viktoriya ; Bowen, David T. ; Mills, Ken I. ; Boultwood, Jacqueline ; Guinn, Barbara‐Ann</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.12352</identifier><identifier>PMID: 23594062</identifier><identifier>CODEN: BJHEAL</identifier><language>eng</language><publisher>Oxford: Blackwell</publisher><subject>Antigens, Neoplasm - biosynthesis ; Antigens, Neoplasm - genetics ; Antigens, Neoplasm - metabolism ; Biological and medical sciences ; Biomarkers, Tumor - biosynthesis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Gene Expression Profiling ; Hematologic and hematopoietic diseases ; Humans ; Kaplan-Meier Estimate ; leukaemia antigens ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; myelodysplastic syndrome ; Myelodysplastic Syndromes - genetics ; Myelodysplastic Syndromes - metabolism ; PReferentially expressed Antigen of the Melanoma Gene ; survival ; Tumors ; tumour antigens</subject><ispartof>British journal of haematology, 2013-07, Vol.162 (2), p.282-285</ispartof><rights>2013 John Wiley &amp; Sons Ltd</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</citedby><cites>FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjh.12352$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjh.12352$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27512041$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23594062$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liberante, Fabio G.</creatorcontrib><creatorcontrib>Pellagatti, Andrea</creatorcontrib><creatorcontrib>Boncheva, Viktoriya</creatorcontrib><creatorcontrib>Bowen, David T.</creatorcontrib><creatorcontrib>Mills, Ken I.</creatorcontrib><creatorcontrib>Boultwood, Jacqueline</creatorcontrib><creatorcontrib>Guinn, Barbara‐Ann</creatorcontrib><title>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Antigens, Neoplasm - biosynthesis</subject><subject>Antigens, Neoplasm - genetics</subject><subject>Antigens, Neoplasm - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - biosynthesis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Gene Expression Profiling</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>leukaemia antigens</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>myelodysplastic syndrome</subject><subject>Myelodysplastic Syndromes - genetics</subject><subject>Myelodysplastic Syndromes - metabolism</subject><subject>PReferentially expressed Antigen of the Melanoma Gene</subject><subject>survival</subject><subject>Tumors</subject><subject>tumour antigens</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM9u1DAQhy0EokvhwAsgX5BAalo7_xofS9WyoCIQgnM0diati2OnHi8lz9CXxu0ucGIuPsznb2Z-jL2U4lDmOtLXV4eyrJryEVvJqm2KUtbyMVsJIY4LKepujz0juhZCVqKRT9leZlUt2nLF7tb28oqDH7gLtwdcbxL3IXHrE8YJBwsJD_iXryefzjj-miMS2eC5w5_oiENEPocQ-RzDpQ-UrOETxB8YKRv4tKALw0Kzg4cWLX6IYUIOiQ-WECh_z0r0CVLWPmdPRnCEL3bvPvt-fvbtdF1cfH7_4fTkojCVEmWhhDC10sI0Wo0wgNLdCPmerjVSmbbGQepaQNd10A5mGAVg1WqtFHTl2DSy2mdvtt689s0GKfWTJYPOgcewoV5WnRRKlW2b0bdb1MRAFHHs52jziUsvRX-ffZ-z7x-yz-yrnXajc3R_yT9hZ-D1DgAy4MYI3lj6xx03shT1_X5HW-7WOlz-P7F_93G9Hf0bquidZg</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Liberante, Fabio G.</creator><creator>Pellagatti, Andrea</creator><creator>Boncheva, Viktoriya</creator><creator>Bowen, David T.</creator><creator>Mills, Ken I.</creator><creator>Boultwood, Jacqueline</creator><creator>Guinn, Barbara‐Ann</creator><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</title><author>Liberante, Fabio G. ; Pellagatti, Andrea ; Boncheva, Viktoriya ; Bowen, David T. ; Mills, Ken I. ; Boultwood, Jacqueline ; Guinn, Barbara‐Ann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3902-900c49b0c5b9fada9b8fa59486c19c64ed1b40a888a6dcdf0ae36bb99a82f5513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Antigens, Neoplasm - biosynthesis</topic><topic>Antigens, Neoplasm - genetics</topic><topic>Antigens, Neoplasm - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - biosynthesis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Gene Expression Profiling</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>leukaemia antigens</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>myelodysplastic syndrome</topic><topic>Myelodysplastic Syndromes - genetics</topic><topic>Myelodysplastic Syndromes - metabolism</topic><topic>PReferentially expressed Antigen of the Melanoma Gene</topic><topic>survival</topic><topic>Tumors</topic><topic>tumour antigens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liberante, Fabio G.</creatorcontrib><creatorcontrib>Pellagatti, Andrea</creatorcontrib><creatorcontrib>Boncheva, Viktoriya</creatorcontrib><creatorcontrib>Bowen, David T.</creatorcontrib><creatorcontrib>Mills, Ken I.</creatorcontrib><creatorcontrib>Boultwood, Jacqueline</creatorcontrib><creatorcontrib>Guinn, Barbara‐Ann</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liberante, Fabio G.</au><au>Pellagatti, Andrea</au><au>Boncheva, Viktoriya</au><au>Bowen, David T.</au><au>Mills, Ken I.</au><au>Boultwood, Jacqueline</au><au>Guinn, Barbara‐Ann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2013-07</date><risdate>2013</risdate><volume>162</volume><issue>2</issue><spage>282</spage><epage>285</epage><pages>282-285</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><coden>BJHEAL</coden><cop>Oxford</cop><pub>Blackwell</pub><pmid>23594062</pmid><doi>10.1111/bjh.12352</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2013-07, Vol.162 (2), p.282-285
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_1381099266
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content
subjects Antigens, Neoplasm - biosynthesis
Antigens, Neoplasm - genetics
Antigens, Neoplasm - metabolism
Biological and medical sciences
Biomarkers, Tumor - biosynthesis
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Gene Expression Profiling
Hematologic and hematopoietic diseases
Humans
Kaplan-Meier Estimate
leukaemia antigens
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
myelodysplastic syndrome
Myelodysplastic Syndromes - genetics
Myelodysplastic Syndromes - metabolism
PReferentially expressed Antigen of the Melanoma Gene
survival
Tumors
tumour antigens
title High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A19%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20and%20low,%20but%20not%20intermediate,%20PRAME%20expression%20levels%20are%20poor%20prognostic%20markers%20in%20myelodysplastic%20syndrome%20at%20disease%20presentation&rft.jtitle=British%20journal%20of%20haematology&rft.au=Liberante,%20Fabio%20G.&rft.date=2013-07&rft.volume=162&rft.issue=2&rft.spage=282&rft.epage=285&rft.pages=282-285&rft.issn=0007-1048&rft.eissn=1365-2141&rft.coden=BJHEAL&rft_id=info:doi/10.1111/bjh.12352&rft_dat=%3Cproquest_cross%3E1381099266%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1381099266&rft_id=info:pmid/23594062&rfr_iscdi=true